Chunlai Feng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The development of drug resistance in cancer cells is one of the major obstacles to achieving effective chemotherapy. We hypothesized that the combination of a doxorubicin (Dox) prodrug and microRNA (miR)21 inhibitor might show synergistic antitumor effects on drug-resistant breast cancer cells. In this study, we aimed to develop new high-density(More)
  • 1